AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,024 | -8.4% | 32,815 | -5.4% | 0.00% | 0.0% |
| Q2 2023 | $435,617 | +111883.8% | 34,683 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $389 | -6.7% | 35,114 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $417 | -99.8% | 34,172 | +34.4% | 0.00% | 0.0% |
| Q3 2022 | $265,000 | -2.2% | 25,431 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $271,000 | +8.8% | 25,243 | -4.2% | 0.00% | 0.0% |
| Q1 2022 | $249,000 | -5.3% | 26,338 | +15.5% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | +29.6% | 22,799 | +10.6% | 0.00% | 0.0% |
| Q1 2021 | $203,000 | +163.6% | 20,607 | +33.1% | 0.00% | -75.0% |
| Q4 2016 | $77,000 | -80.0% | 15,477 | -78.1% | 0.00% | -81.0% |
| Q2 2016 | $385,000 | +57.8% | 70,602 | +180.1% | 0.02% | +31.2% |
| Q4 2015 | $244,000 | – | 25,206 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |